Neuroprotective effects of gelsolin during murine stroke

Journal of Clinical Investigation

Volumn 103, Issue 3, 1999, Pages 347-354

  Endres, Matthias ^a   Fink, Klaus ^b   Zhu, Jinmin ^a   Stagliano, Nancy E ^a   Bondada, Vimala ^c   Geddes, James W ^c   Azuma, Toshifumi ^d   Mattson, Mark P ^c   Kwiatkowski, David J ^d   Moskowitz, Michael A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF BONN   (Germany)

^c UNIVERSITY OF KENTUCKY   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHALASIN; GELSOLIN;

ACTIN FILAMENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL DAMAGE; CELL SURVIVAL; DEPOLYMERIZATION; HEART INFARCTION SIZE; HIPPOCAMPUS; IMAGE ANALYSIS; IMMUNOBLOTTING; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; STROKE; SYNAPTOSOME; TISSUE INJURY;

EID: 0032959847     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI4953     Document Type: Article

References (41)

1. Choi, D.W. 1995. Calcium: still center-stage in hypoxic-ischemic neuronal death. Trends Neurosci. 18:58-60.
2. Choi, D.W. 1988. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1:623-634.
3. MacDermott, A.B., Mayer, M.L., Westbrook, G.L., Smith, S.J., and Barker, J.L. 1986. NMDA-receptor activation increases cytoplasmic calcium concentration in cultured spinal cord neurons. Nature. 321:519-522.
4. Park, P.C., Nehls, D.G., Graham, D.I., Teasdale, G.M., and McCulloch, J. 1988. The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat. Ann. Neurol. 24:43-51.
5. Rosenmund, C., and Westbrook, G.L. 1993. Calcium-induced actin depolymerization reduces NMDA channel activity. Neuron. 10:805-814.
6. 2+. Neuron. 10:797-804.
7. 1. Exp. Neurol. 133:153-163.
8. Schafer, D.A., and Cooper, J.A. 1995. Control of actin assembly at filament ends. Ann. Rev. Cell Dev. Biol. 11:497-518.
9. Janmey, P.A., and Stossel, T.P. 1987. Modulation of gelsolin function by phosphatidylinositol 4,5-biphosphate. Nature. 325:362-364.
10. Kwiatkowski, D.J., Mehl, R., and Yin, H.L. 1988. Genomic organization and biosynthesis of secreted and cytoplasmic forms of gelsolin. J. Cell. Biol. 106:375-384.
11. Kwiatkowski, D.J., Janmey, P.A., and Yin, H.L. 1989. Identification of critical functional and regulatory domains in gelsolin. J. Cell. Biol. 108:1717-1726.
12. Azuma, T., Witke, W., Stossel, T.P., Hartwig, J.H., and Kwiatkowski, D.J. 1998. Gelsolin is a downstream effector of rac for fibroblast motility. EMBO J. 17:1362-1379.
13. Witke, W., et al. 1995. Hemostatic, inflammatory, and fibroblast responses are blunted in mice lacking gelsolin. Cell. 81:41-51.
14. Tanaka, J., Kira, M., and Subue, K. 1993. Gelsolin is localized in neuronal growth cones, Dev. Brain Res. 76:268-271.
15. Furukawa, K., et al. 1997. The actin-severing protein gelsolin modulates calcium channel and NMDA receptor activities and vulnerability to excitotoxicity in hippocampal neurons. J. Neurosci. 17:8178-8186.
16. Mattson, M.P., Dou, P., and Kater, S.B. 1988. Outgrowth-regulating actions of glutamate in isolated hippocampal pyramidal neurons. J. Neurosci. 8:2087-2100.
17. Mattson, M.P., Murrain, M., Guchrie, P.B., and Kater, S.B. 1989. Fibroblast growth factor and glutamate: opposing actions in the generation and degeneration of hippocampal architecture. J. Neurosci. 9:3728-3740.
18. Mattson, M.P., Barger, S.W., Begley, J.G., and Mark, R.J. 1995. Calcium, free radicals, and excitotoxic neuronal death in primary cell culture. Methods Cell. Biol. 46:187-216.
19. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260:3440-3450.
20. 2+ and glutamate-release of rat cerebrocortical synaptosomes. Neuropharmacology. 35:179-186.
21. +- and veratridine-induced increases of cytosolic calcium concentration in rat cortical synaptosomes. Naunyn-Schmiedeberg's Arch. Pharmacol. 356:797-805.
22. Hara, H., et al. 1997. Inhibition of interleukin-1β converting enzyme family proteases reduces ischemic and excitotoxic damage. Proc. Natl. Acad. Sci. USA. 94:2007-2012.
23. Endres, M., et al. 1998. Attenuacion of delayed neuronal death after mild focal ischemia in mice by inhibition of the caspase family. J. Cereb. Blood Flow Metab. 18:238-247.
24. Endres, M., Wang, Z.-Q., Namura, S., Waeber, C., and Moskowitz, M.A. 1997. Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase. J. Cereb. Blood Flow Metab. 17:1143-1151.
25. Huang, Z., et al. 1994. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science. 265:1883-1885.
26. Swanson, R.A., et al. 1990. A semiautomated method for measuring brain infarct volume. J. Cereb. Blood Flow Metab. 10:290-293.
27. Kothakota, S., et al. 1997. Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. Science. 278:294-298.
28. Smith-Swintosky, V.L., et al. 1996. Metapyrone, an inhibitor of glucocorticoid production, reduces brain injury by focal and global ischemia and seizures. J. Cereb. Blood Flow Metab. 16:585-598.
29. Robert-Lewis, J.M., et al. 1994. Immunolocalization of calpain I-mediated spectrin degradation to vulnerable neurons in the ischemic gerbil brain. J. Neurosci. 14:3934-3944.
30. Pettigrew, L.C., et al. 1996. Microtubular proteolysis in focal cerebral ischemia. J. Cereb. Blood Flow Metab. 16:1189-1202.
31. Yao, H., et al. 1995. Local cerebral glucose utilization and cytoskeletal proteoiysis as indices of evolving focal ischemic injury in core penumbra. J. Cereb. Blood Flow Metab. 15:398-408.
32. Belayev, L., Busto, R., Watson, B.D., and Ginsberg, D.M. 1995. Post-ischemic administration of HU-211, a novel non-competitive NMDA antagonist, protects against blood-brain barrier disruption in photochemical cortical infarction in rats: a quantitative study. Brain Res. 702:266-270.
33. Du, C., Hu, R., Hsu, C.Y., and Choi, W.D. 1996. Dextrorphan reduces infarct volume, vascular injury, and brain edema after ischemic brain injury. J. Neurotrauma. 13:215-222.
34. Baskaya, M.K., et al. 1997. Protective effects of ifenprodil on ischemic injury size, blood-brain barrier breakdown, and edema formation in focal cerebral ischemia. Neurosurgery. 40:364-370.
35. Namura, S., et al. 1998. Activation and cleavage of caspase-3 in experimental cerebral ischemia in mice. J. Neurosci. 18:3659-3668.
36. Ayata, C., et al. 1997. Reduced striatal NMDA excitotoxicity in type I nitric oxide synthase knockout mice. J. Neurosci. 17:6908-6917.
37. 2+ requirement. J. Biol. Chem. 268:8999-9004.
38. Kuida, K., et al. 1996. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature. 384:368-372.
39. Li, Y., et al. 1995. Ultrastructural and light microscopic evidence of apoptosis after middle cerebral artery occlusion in the rat. Am. J. Pathol. 146:1045-1051.
40. Hill, I.E., MacManus, V., Rasquinha, I., and Tuor, U.I. 1995. DNA fragmentation indicative of apoptosis following unilateral cerebral hypoxia-ischemia in the neonatal rat. Brain Res. 676:398-403.
41. Ohtsu, M., et al. 1997. Inhibition of apoptosis by the actin-regulatory protein gelsolin. EMBO J. 16:4650-4656.